| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035054C Novel isoxazolines as antiinflammatory agents |
| 06/03/1997 | US5635524 Cyclization; salt formation; separation; stimulant for beta-adrenergic receptors |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635495 Antiarthritic agents treating bone disorder, osteoporosis; calcium channel blockers |
| 06/03/1997 | CA2040517C 1,8-naphthyridin-2-one derivatives |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019084A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997019074A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 05/29/1997 | WO1997019053A1 Metalloproteinase inhibitors |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018802A1 Pharmaceutical compositions comprising flurbiprofen |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775151A2 Sialic acid/fucose based medicaments |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0775140A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775131A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0710107A4 N,n,n-trimethylsphingosine derivatives |
| 05/28/1997 | EP0668851B1 A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150758A Process for preparation of acanthoic acid and pharmaceutical composition comprising same |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633279 5-substituted derivatives of mycophenolic acid |
| 05/27/1997 | US5633277 Antiinflammatory |
| 05/27/1997 | US5633272 Substituted isoxazoles for the treatment of inflammation |
| 05/27/1997 | US5633266 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
| 05/27/1997 | US5633257 Phosphodiesterase inhibitor |
| 05/27/1997 | US5633253 Substituted thiosemicarbazonic acid esters |
| 05/27/1997 | US5633232 Tachykinin antagonist dipeptides |
| 05/27/1997 | US5633145 TNFα receptor-derived binding protein |
| 05/24/1997 | CA2190801A1 Leukotriene antagonistic benzoic acid derivatives |
| 05/22/1997 | WO1997018220A1 A heterocyclic chemical compound |
| 05/22/1997 | WO1997018208A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | WO1997018207A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | WO1997018206A1 Morpholine derivatives and their use as therapeutic agents |
| 05/22/1997 | WO1997018191A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | WO1997018188A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 05/22/1997 | WO1997017978A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 05/22/1997 | WO1997017971A1 Use of epinastine in the treatment of pain |
| 05/22/1997 | WO1997017947A1 Directly compressible high load acetaminophen formulations |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | CA2237558A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | CA2237524A1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | CA2235126A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/21/1997 | EP0774257A2 Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration |
| 05/21/1997 | EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/21/1997 | EP0773932A1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 05/21/1997 | EP0773931A1 Quinoline derivatives as leukotriene antagonists |
| 05/21/1997 | EP0773930A1 Aromatic amino ethers as pain relieving agents |
| 05/21/1997 | EP0773795A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0623138B1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150389A Extracts of stephania tetrandra for inhibition of interleukin-6 production |
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/20/1997 | US5631286 Compounds useful for treating allergic or inflammatory diseases |
| 05/20/1997 | US5631283 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| 05/20/1997 | US5631245 Di-beta-glycopyranosylamine from glucose and nitrogen base |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997011668A3 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 05/15/1997 | DE19542281A1 Verwendung von Epinastin für die Behandlung von Schmerzen Use of epinastine in the treatment of pain |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772606A1 Substituted thiazoles for the treatment of inflammation |
| 05/14/1997 | EP0772601A1 4,5-substituted imidazolyl compounds for the treatment of inflammation |
| 05/14/1997 | EP0772600A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 05/14/1997 | EP0772597A1 3,4-substituted pyrazoles for the treatment of inflammation |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0772441A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 05/14/1997 | EP0772396A1 Method of regulating immune function |
| 05/14/1997 | CN1149877A Novel elastase inhibitor |
| 05/14/1997 | CN1149876A Perfluoroalkyl ketone inhibitors of elastase and processes for making same |
| 05/14/1997 | CN1149870A Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity |
| 05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
| 05/14/1997 | CN1149583A Enderma agent receptor antagonist |
| 05/14/1997 | CN1034869C Peptide compound and its preparing method for pharmaceutical salt |
| 05/14/1997 | CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound |
| 05/13/1997 | US5629436 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress |
| 05/13/1997 | US5629339 Chronic venous insufficiency |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |